Redeye: Dynavox - Strong execution in 2024
Redeye continues to see a compelling long-term investment case. The stronger-than-expected organic growth in the quarter puts the growth for the year above 22%. We have made slight adjustments due to the continued strong momentum appearent in the quarter, which likely will continue in 2025e. The optimistic outlook remains, with continued momentum both in the short and medium term. We increase our Base case to SEK 76 per share. Following this report, we also change the lead analyst.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/